SPI
DGX icon

Santori & Peters Inc’s Quest Diagnostics DGX Stock Holding History

Santori & Peters Inc’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-2,621
Closed -$210K – 58
2020
Q1 		$210K Hold
2,621
– – 0.18% 66
2019
Q4 		$279K Hold
2,621
– – 0.18% 62
2019
Q3 		$280K Hold
2,621
– – 0.2% 58
2019
Q2 		$266K Buy
+2,621
New +$252K 0.19% 60
2018
Q1 		– Sell
-40
Closed -$3K – 181
2017
Q4 		$3K Buy
+40
New +$3.79K ﹤0.01% 511

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Santori & Peters Inc's DGX Position: Q2 2020 in Review

Santori & Peters Inc sold out of Quest Diagnostics (DGX) in Q2 2020, closing a stake of 2,621 shares — an estimated $210K sold.

Santori & Peters Inc first reported a position in DGX in Q4 2017 and held it in 5 quarters. The position peaked at $280K in Q3 2019. 748 funds tracked by Wall St. Rank hold DGX as of Q2 2020.

  • Santori & Peters Inc reported no remaining Quest Diagnostics position as of Q2 2020 after selling out during the quarter.
  • Santori & Peters Inc sold 2,621 Quest Diagnostics shares in Q2 2020, an estimated $210K.
  • Santori & Peters Inc first reported a position in Quest Diagnostics in Q4 2017 and held it in 5 quarters.
  • Santori & Peters Inc's Quest Diagnostics position peaked at $280K in Q3 2019.
  • 748 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2020.

Based on Santori & Peters Inc's 13F filing for Q2 2020, filed 7 Jul 2020.